Abstract
The present work presents a “from gene defect to clinics” pathogenesis study of a patient with a hitherto unreported mutation in the CPT1A gene. In early childhood, the patient developed a life-threatening episode (hypoketotic hypoglycemia, liver cytolysis, and hepatomegaly) evocative of a mitochondrial fatty acid oxidation disorder, and presented deficient fibroblast carnitine palmitoyltransferase 1 (CPT1) activity and homozygosity for the c.1783 C > T nucleotide substitution on exon 15 of CPT1A (p.R595W mutant). While confirming CPT1A deficiency, whole blood de novo acylcarnitine synthesis and the levels of carnitine and its esters formally linked intracellular free-carnitine depletion to intracellular carnitine esterification. Sequence alignment and modeling of wild-type and p.*R595W CPT1A proteins indicated that the Arg595 targeted by the mutated codon is phylogenetically well conversed. It contributes to a hydrogen bond network with neighboring residues Cys304 and Met593 but does not participate in the catalysis and carnitine pocket. Its replacement by tryptophan induces steric hindrance with the side chain of Ile480 located in α-helix 12, affecting protein architecture and function. This hindrance with Ile480 is also originally described with tryptophan 304 in the known mutant p.C304W CPT1A, suggesting that the mechanisms that invalidate CPT1A activity and underlie pathogenesis could be common in both the new (p.R595W) and previously described (p.C304W) mutants.
Competing interests: None declared
M. Fontaine and A.F. Dessein are co-first authors.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bennett MJ, Narayan SB, Santani AB (2005) Carnitine palmitoyltransferase 1A. In: Pagon RA, Bird TD, Dolan CR, Stephens K (eds) Gene reviews [Internet]. University of Washington, Seattle, WA, USA [updated 2010]
Bonnefont JP, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J (2004) Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspect Med 25:495–520
Britton CH, Mackey DW, Esser V et al (1997) Fine chromosome mapping of the genes for human liver and muscle carnitine palmitoyltransferase I. Genomics 40:209–211
Brown NF, Mullur RS, Subramanian I et al (2001) Molecular characterization of L-CPT I deficiency in six patients: insights into function of the native enzyme. J Lipid Res 42:1134–1142
Combet C, Jambon M, Deléage G, Geourjon C (2002) Geno3D: automatic comparative molecular modelling of protein. Bioinformatics 18:213–214
Cook GA, Mynatt RL, Kashfi K (1994) Yonetani-Theorell analysis of hepatic carnitine palmitoyltransferase-I inhibition indicates two distinct inhibitory binding sites. J Biol Chem 269:8803–8807
Demaugre F, Bonnefont JP, Mitchell G et al (1988) Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: two distinct entities. Pediatr Res 24:308–311
Dessein AF, Fontaine M, Dobbelaere D et al (2009) Deuterated palmitate-driven acylcarnitine formation by whole-blood samples for a rapid diagnostic exploration of mitochondrial fatty acid oxidation disorders. Clin Chim Acta 406:23–26
Esser V, Britton CH, Weis BC, Foster DW, McGarry JD (1993) Cloning, sequencing, and expression of a cDNA encoding rat liver carnitine palmitoyltransferase I. Direct evidence that a single polypeptide is involved in inhibitor interaction and catalytic function. J Biol Chem 268:5817–5822
Fontaine M, Porchet N, Largilliere C et al (1989) Biochemical contribution to diagnosis and study of a new case of D-glyceric acidemia/aciduria. Clin Chem 35:2148–2151
Fontaine M, Briand G, Vallée L et al (1996) Acylcarnitine removal in a patient with acyl-CoA beta-oxidation deficiency disorder: effect of L-carnitine therapy and starvation. Clin Chim Acta 252:109–122
Haworth JC, Demaugre F, Booth FA et al (1992) Atypical features of the hepatic form of carnitine palmitoyltransferase deficiency in a Hutterite family. J Pediatr 121:553–557
Houten SM, Wanders RJ (2010) A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation. J Inherit Metab Dis 33:469–477. http://www.expasy.org/spdbv
Kashfi K, Cook GA (1999) Topology of hepatic mitochondrial carnitine palmitoyltransferase I. Adv Exp Med Biol 466:27–42
Morillas M, Gómez-Puertas P, Rubi BA et al (2002) Structural model of a malonyl-CoA-binding site of carnitine octanoyltransferase and carnitine palmitoyltransferase I: mutational analysis of malonyl-CoA affinity domain. J Biol Chem 277:11473–11480
Morillas M, Gómez-Puertas P, Bentebibel A et al (2003) Identification of conserved amino acid residues in rat liver carnitine palmitoyltransferase 1 critical for malonyl-CoA- inhibition. Mutation of methionine 593 abolishes malonyl-CoA inhibition. J Biol Chem 278:9058–9063
Morillas M, López-Viñas E, Valencia A et al (2004) Structural model of carnitine palmitoyltransferase I based on the carnitine acetyltransferase crystal. Biochem J 379:777–784
Murthy MS, Pande SV (1987) Malonyl-CoA binding site and the overt carnitine palmitoyltransferase activity reside on the opposite sides of the outer mitochondrial membrane. Proc Natl Acad Sci USA 84:378–382
Olpin SE, Allen J, Bonham JR et al (2001) Features of carnitine palmitoyltransferase type I deficiency. J Inherit Metab Dis 24:35–42
Price NT, van der Leij FR, Jackson VN et al (2002) A novel brain-expressed protein related to carnitine palmitoyltransferase 1. Genomics 80:433–442
Sierra AY, Gratacós E, Carrasco P et al (2008) CPT1c is localized in endoplasmic reticulum of neurons and has carnitine palmitoyltransferase activity. J Biol Chem 283:6878–6885
Vianey-Saban C, Mousson B, Bertrand C et al (1993) Carnitine palmitoyl transferase I deficiency presenting as a Reye-like syndrome without hypoglycaemia. Eur J Pediatr 152:334–338
Vockley J (1994) The changing face of disorders of fatty acid oxidation. Mayo Clin Proc 69:249–257
Vockley J, Whiteman DA (2002) Defects of mitochondrial beta-oxidation: a growing group of disorders. Neuromuscul Disord 12:235–246
Wolfgang MJ, Lane MD (2011) Hypothalamic malonyl-CoA and CPT1c in the treatment of obesity. FEBS J 278:552–558
Wolfgang MJ, Kurama T, Dai Y et al (2006) The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. Proc Natl Acad Sci USA 103:7282–7287
Yamamoto S, Abe H, Kanazawa M et al (1994) Clinical, biochemical and molecular studies in fatty acid oxidation disorders (1): a Japanese case with carnitine palmitoyltransferase I deficiency presenting familial Reye-like episode. In: VI International congress inborn errors of metabolism, Milano, Italy, 27–31 May 1994
Yamazaki N, Shinohara Y, Shima A, Terada H (1995) High expression of a novel carnitine palmitoyltransferase I like protein in rat brown adipose tissue and heart: isolation and characterization of its cDNA clone. FEBS Lett 363:41–45
Acknowledgments
The authors thank the patient, the patient’s parents and laboratory volunteer controls for participating in this study. Written informed consent was obtained from the patient and the patient’s parents for the present report. The authors gratefully acknowledge J.C. Vienne, I. Kumorek, F. Hottevart and A. Kerkove for their technical assistance. This work was supported by grants from the French Ministère de la Santé (PHRC 2003R/1903) and FMO (Fédération des Maladies Orphelines).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Jerry Vockley
Appendices
Synopsis
Features of a new c.1783 C > T nucleotide substitution in CPT1A exon 15 (p.R595W) include deficient palmitoylcarnitine formation from deuterated palmitate (assessed by a novel and safe in situ assay), molecular pathogenesis mechanisms that also apply partially to the CPT1A C304W mutant (steric hindrance with Ile 480 and α-helix 12), and a link between intracellular carnitine depletion and esterification.
Competing Interest
None declared
Rights and permissions
Copyright information
© 2012 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fontaine, M. et al. (2012). A Novel Mutation in CPT1A Resulting in Hepatic CPT Deficiency. In: JIMD Reports - Case and Research Reports, 2012/3. JIMD Reports, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2011_94
Download citation
DOI: https://doi.org/10.1007/8904_2011_94
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-28128-0
Online ISBN: 978-3-642-28129-7
eBook Packages: MedicineMedicine (R0)